Feb 9 (Reuters) - China Resources Pharmaceutical Group Ltd 3320.HK:
POTENTIAL DISPOSAL OF TIANMAI BIOTECHNOLOGY
A MINIMUM LISTING PRICE OF APPROXIMATELY RMB1.42 BILLION
UNIT INITIATED POTENTIAL DISPOSAL OF 17.87% STAKE IN HEFEI TIANMAI BIOTECHNOLOGY DEVELOPMENT
DISPOSAL THROUGH PUBLIC TENDER PROCESS ON SHANGHAI UNITED ASSETS AND EQUITY EXCHANGE
Further company coverage: 3320.HK
((Reuters.Briefs@thomsonreuters.com;))